Latest news
Why Have Clinuvel Pharmaceuticals (ASX:CUV) Shares Fallen Despite Recent Clinical Updates? - KalkineKalkine · Fri, 07 Aug 2026 12:13:00 GMTBeyond the Daily Move: Why Clinuvel Pharmaceuticals (ASX:CUV) Remains a Unique Name in Australian Biotech? - KalkineKalkine · Fri, 07 Aug 2026 02:51:00 GMTCUVL | Clinuvel Pharmaceuticals Limited American Institutional Ownership - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 04:34:36 GMTClinuvel Pharmaceuticals (OTC: CLVLF) maps vitiligo trial benchmarks and plans - Stock TitanStock Titan · Thu, 30 Jul 2026 10:10:30 GMTCLVLY SEC Filings - Clinuvel Pharmaceuticals Ltd 10-K, 10-Q, 8-K Forms - Stock TitanStock Titan · Thu, 30 Jul 2026 10:10:06 GMTJefferies Maintains CLINUVEL PHARMACEUTICALS LTD(CLVLF.US) With Buy Rating, Raises Target Price to $28.34 - MoomooMoomoo · Wed, 29 Jul 2026 07:00:00 GMTClinuvel Pharmaceuticals Strengthens Supply Chain as Part of Commercial Preparations for North American Vitiligo Market - marketscreener.commarketscreener.com · Wed, 29 Jul 2026 07:00:00 GMTOne Healthcare Stock with Long-Term Growth Prospects - Clinuvel Pharmaceuticals Limited - KalkineKalkine · Tue, 28 Jul 2026 19:53:24 GMT